## Abstract 2006, there was, no single instrument (questionnaire or scale) for attempting a comprehensive assessment of the wide range of nonmotor symptoms (NMS) of Parkinson's disease (PD). The PD nonmotor group, a multidisciplinary group of experts including patient group representatives develope
Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study
โ Scribed by Sean S. O'Sullivan; David R. Williams; David A. Gallagher; Luke A. Massey; Laura Silveira-Moriyama; Andrew J. Lees
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 66 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Nonmotor symptoms (NMS) are increasingly recognized as a significant cause of morbidity in later stages of Parkinson's disease (PD). Prodromal NMS are also a well recognized component of the clinical picture in some patients but the prevalence of NMS as presenting complaints, and their impact on clinical management, in pathologicallyโproven cases of PD is unknown. The presenting complaints of 433 cases of pathologicallyโproven PD archived at the Queen Square Brain Bank for Neurological Diseases were identified from the clinical case notes. 91/433 (21%) of patients with PD presented with NMS of which the most frequent were pain (15%), urinary dysfunction (3.9%), anxiety, or depression (2.5%). Presenting with NMS is associated with a delayed diagnosis of PD (MannโWhitney U, P = 0.001). These patients were more likely to be misdiagnosed initially and were more likely to have been referred to orthopedeic surgeons or rheumatologists than neurologists (nonmotor group 5.5% vs. motor group 44.2%, ฯ^2^ P < 0.0001). NMS are commonly seen as presenting complaints in pathologically confirmed PD, and initial misdiagnosis may be associated with potentially inappropriate medical interventions. Presenting with NMS does not affect the motor response to medication, but is associated with shorter disease duration (ฯ^2^ P = 0.016). ยฉ 2007 Movement Disorder Society
๐ SIMILAR VOLUMES
## Abstract Background: In patients with Parkinson's disease (PD), asymmetric motor signs provide an interesting model to evaluate whether asymmetric nigrostriatal degeneration can affect neuropsychological function and other nonmotor symptoms (NMS). This study was designed to evaluate the predomin
Echocardiogram revealed diffuse hypokinesis, dilatation of left ventricular cavity, and thinning of left ventricular wall. Ejection fraction was decreased to 49%. Cardiac muscle biopsy demonstrated hypertrophied cardiomyocyte and interstitial fibrosis of left ventricle. A gastrocnemius muscle biopsy
We describe the clinicopathological findings in a patient aged 63 years at death who, at age 55 years, developed levodopa-responsive parkinsonism with no atypical features. A diagnosis of idiopathic Parkinson's disease (PD) was made. During the clinical course, fluctuations and dyskinesias appeared.
## Abstract Switching from oral medications to continuous infusion of levodopa/carbidopa gel reduces motor complications in advanced Parkinson's disease (PD), but effects on nonmotor symptoms (NMSs) are unknown. In this prospective openโlabel observational study, we report the effects of intrajejun